VP
venBio Partners Portfolio holdings
AUM
$115M
This Quarter Return
-20.59%
1 Year Return
-33.99%
3 Year Return
+221.07%
5 Year Return
+224.54%
10 Year Return
–
AUM
$124M
AUM Growth
+$124M
(-28%)
Cap. Flow
-$2.62M
Cap. Flow
% of AUM
-2.12%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Harmony Biosciences
HRMY
|
$1.66M |
| 2 |
ARTV
Artiva Biotherapeutics, Inc. Common Stock
ARTV
|
$963K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Pharvaris
PHVS
$1.39B
| $67.3M | 54.5% | 4,289,304 | – | – |
|
|
ALMS
2
Alumis Inc. Common Stock
ALMS
$479M
| $17.1M | 13.85% | 2,787,398 | – | – |
|
|
3
Harmony Biosciences
HRMY
$2.12B
| $16.2M | 13.14% | 489,194 -50,000 | -9% | -$1.66M |
|
|
SLRN
4
DELISTED
ACELYRIN
SLRN
| $9.4M | 7.61% | 3,806,410 | – | – |
|
5
ALX Oncology
ALXO
$62.7M
| $6.04M | 4.89% | 9,699,925 | – | – |
|
6
Lyell Immunopharma
LYEL
$213M
| $3.82M | 3.09% | 7,102,190 | – | – |
|
|
ARTV
7
Artiva Biotherapeutics, Inc. Common Stock
ARTV
$76.7M
| $3.6M | 2.91% | 1,198,975 -320,996 | -21% | -$963K |
|